BioAtla Inc (BCAB) Stock Price, Quote, News & History

BCABNASDAQ
$4.02
-0.0397-0.98%
Last update: Jul 15, 2:01 PM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-37.18M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
6.78M
Free Cash Flow (TTM)
-37.18M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-30.40M

Analyst Rating and Forecast

12345
4.5
Strong Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$10.77M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
2.52
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-1039.00%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$22.48

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$1.96M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$3.96
Close
-
Volume / Avg.
29.99K / 51.70K
Day Range
$3.80 - $4.07
52 Wk Range
3.12 - 71.50
Market Cap
$6.66M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
52
Short Interest
9.18%
Days to Cover
2.4

About

Sector
Health Care
Industry
Biotechnology
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbot...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy BioAtla (BCAB) stock?

A

You can purchase shares of BioAtla (NASDAQ:BCAB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BioAtla (BCAB) competitors?

A

There are no as such competitors for BioAtla.

Q

What is the forecast, or price target, for BioAtla (BCAB) stock?

A

BioAtla has a consensus price target of $11.25.

Q

What is the current price for BioAtla (BCAB)?

A

The stock price for BioAtla (NASDAQ: BCAB) is $4.0203 last updated July 15, 2026 at 2:01 PM EDT.

Q

Does BioAtla (BCAB) pay a dividend?

A

There are no upcoming dividends for BioAtla.

Q

When is BioAtla (NASDAQ:BCAB) reporting earnings?

A

BioAtla does not have any upcoming earnings scheduled.

Q

Is BioAtla (BCAB) going to split?

A

There is no upcoming split for BioAtla.

Q

What sector and industry does BioAtla (BCAB) operate in?

A

BioAtla is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.